Marksans Pharma

{
  "main_header": {
    "sid": 604869,
    "name": "Marksans Pharma",
    "stock_name": "Marksans Pharma",
    "full_name": "Marksans Pharma Ltd",
    "name_url": "stocks-analysis/marksans-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "251.80",
    "chg": 2.2,
    "chgp": "0.88%",
    "dir": 1,
    "prev_price": "249.60",
    "mcapval": "11,410.66 Cr",
    "mcap": "Small Cap",
    "scripcode": 524404,
    "symbol": "MARKSANS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE750C01026",
    "curr_date": "Jun 16, 09:27 AM",
    "curr_time": "09:28 AM",
    "last_traded_at": "Jun 16, 09:27 AM IST",
    "bse_nse_vol": "16.84 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 16, 2026",
    "traded_date_str": "2026 06 16",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/marksans-pharma-604869-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Marksans Pharma Gains 8.22%: Key Financial and Technical Drivers Behind the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-gains-822-key-financial-and-technical-drivers-behind-the-rally-4051396",
        "imagepath": "",
        "date": "2026-06-13 13:02:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 June:</strong> Stock opens at Rs.236.05, up 1.31% despite Sensex decline</p>\n                    <p><strong>9 June:</strong> Intraday high of Rs.252.40 with 7.22% surge; upgraded to Buy rating</p>\n                    <p><strong>10 June:</strong> Reports record quarterly performance; stock dips 2.22%</p>\n                    <p><strong>11 June:</strong> Modest recovery with 1.07% gain</p>\n                    <p><strong>12 June:</strong> Week closes at Rs.252.15, up 1.00% on strong Sensex rally</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.233.00</div><..."
      },
      {
        "title": "Marksans Pharma Ltd Reports Record Quarterly Performance Amid Flat Financial Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-reports-record-quarterly-performance-amid-flat-financial-trend-4044318",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MarksansPharmaL_fintrenddot_4044318.png",
        "date": "2026-06-10 15:00:25",
        "description": "Marksans Pharma Ltd has delivered its strongest quarterly results to date in March 2026, posting record net sales and profitability metrics despite a shift in its financial trend from positive to flat. The pharmaceutical company’s latest performance highlights robust operational execution, though recent market sentiment has tempered its mojo grade to Hold from Buy."
      },
      {
        "title": "Marksans Pharma Ltd Surges 7.22% to Day's High of Rs 252.4 — Outperforms Sector by 6.02 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-hits-intraday-high-with-722-surge-on-9-june-2026-4041320",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MarksansPharmaL_priceRelatedfactors_4041320.png",
        "date": "2026-06-09 15:16:25",
        "description": "The Sensex edged up 0.55% on 09 Jun 2026, yet Marksans Pharma Ltd outpaced the broader market with a robust 7.22% gain, reaching an intraday high of Rs 252.4. This 6.02 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Marksans Pharma Ltd Upgraded to Buy on Strong Financial and Technical Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-upgraded-to-buy-on-strong-financial-and-technical-metrics-4040545",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MarksansPharmaL_mojoScore_4040545.png",
        "date": "2026-06-09 08:58:18",
        "description": "Marksans Pharma Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects the company’s robust quarterly performance, improved management efficiency, and attractive valuation relative to its peers within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Marksans Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-hold-by-marketsmojo-4037041",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MarksansPharmaL_mojoScore_4037041.png",
        "date": "2026-06-08 10:10:40",
        "description": "Marksans Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Marksans Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-4029487",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MarksansPharmaL_technicaldot_4029487.png",
        "date": "2026-06-02 08:05:04",
        "description": "Marksans Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock continues to display a complex interplay of technical indicators that suggest cautious optimism for investors."
      },
      {
        "title": "Marksans Pharma Surges 16.30%: Key Technical and Financial Drivers Behind the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-surges-1630-key-technical-and-financial-drivers-behind-the-rally-4023355",
        "imagepath": "",
        "date": "2026-05-30 16:11:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>25 May:</strong> Technical momentum shifts to mildly bullish with mixed indicator signals</p>\n                    <p><strong>26 May:</strong> Intraday high surge of 13.26% and strong quarterly results announced</p>\n                    <p><strong>27 May:</strong> Financial trend upgraded to positive; Mojo Grade upgraded to Hold</p>\n                    <p><strong>28 May:</strong> Mojo Grade upgraded further to Buy on strong financial and technical performance</p>\n                    <p><strong>29 May:</strong> Technical momentum shifts signal bullish outlook despite minor price dip</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"st..."
      },
      {
        "title": "Marksans Pharma Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-technical-momentum-shifts-signal-bullish-outlook-4019300",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MarksansPharmaL_technicaldot_4019300.png",
        "date": "2026-05-29 08:02:37",
        "description": "Marksans Pharma Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of positive signals from key technical indicators such as MACD, Bollinger Bands, and moving averages, alongside robust returns that have outpaced the broader Sensex over multiple time frames."
      },
      {
        "title": "Marksans Pharma Upgraded to Buy on Strong Financial and Technical Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-upgraded-to-buy-on-strong-financial-and-technical-performance-4017768",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MarksansPharmaL_mojoScore_4017768.png",
        "date": "2026-05-28 08:21:29",
        "description": "Marksans Pharma Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across financial performance, valuation metrics, technical indicators, and overall quality. This upgrade follows the company’s robust quarterly results and positive market momentum, positioning it favourably within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 379,
    "sid": "604869",
    "stock_news_url": "https://www.marketsmojo.com/news/marksans-pharma-604869"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "09-Jun-2026",
      "details": "India Ratings and Research has revised the outlook for the Companys bank loan facilities to Positive from Stable",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Jun-2026",
      "details": "Intimation of schedule for Virtual Investors Conference",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "03-Jun-2026",
      "details": "Newspaper Publication regarding Second 100 day Campaign- Saksham Niveshak",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Marksans Pharma Ltd has declared <strong>80%</strong> dividend, ex-date: 01 Aug 25",
          "dt": "2025-08-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Marksans Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Marksans Pharma Gains 8.22%: Key Financial and Technical Drivers Behind the Rally

2026-06-13 13:02:31

Key Events This Week

8 June: Stock opens at Rs.236.05, up 1.31% despite Sensex decline

9 June: Intraday high of Rs.252.40 with 7.22% surge; upgraded to Buy rating

10 June: Reports record quarterly performance; stock dips 2.22%

11 June: Modest recovery with 1.07% gain

12 June: Week closes at Rs.252.15, up 1.00% on strong Sensex rally

Week Open

Rs.233.00

<...

Read full news article

Marksans Pharma Ltd Reports Record Quarterly Performance Amid Flat Financial Trend

2026-06-10 15:00:25

Marksans Pharma Ltd has delivered its strongest quarterly results to date in March 2026, posting record net sales and profitability metrics despite a shift in its financial trend from positive to flat. The pharmaceutical company’s latest performance highlights robust operational execution, though recent market sentiment has tempered its mojo grade to Hold from Buy.

Read full news article

Marksans Pharma Ltd Surges 7.22% to Day's High of Rs 252.4 — Outperforms Sector by 6.02 Percentage Points

2026-06-09 15:16:25

The Sensex edged up 0.55% on 09 Jun 2026, yet Marksans Pharma Ltd outpaced the broader market with a robust 7.22% gain, reaching an intraday high of Rs 252.4. This 6.02 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

Marksans Pharma Ltd Upgraded to Buy on Strong Financial and Technical Metrics

2026-06-09 08:58:18

Marksans Pharma Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects the company’s robust quarterly performance, improved management efficiency, and attractive valuation relative to its peers within the Pharmaceuticals & Biotechnology sector.

Read full news article

Marksans Pharma Ltd is Rated Hold by MarketsMOJO

2026-06-08 10:10:40

Marksans Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Marksans Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-02 08:05:04

Marksans Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock continues to display a complex interplay of technical indicators that suggest cautious optimism for investors.

Read full news article

Marksans Pharma Surges 16.30%: Key Technical and Financial Drivers Behind the Rally

2026-05-30 16:11:17

Key Events This Week

25 May: Technical momentum shifts to mildly bullish with mixed indicator signals

26 May: Intraday high surge of 13.26% and strong quarterly results announced

27 May: Financial trend upgraded to positive; Mojo Grade upgraded to Hold

28 May: Mojo Grade upgraded further to Buy on strong financial and technical performance

29 May: Technical momentum shifts signal bullish outlook despite minor price dip

Read full news article

Marksans Pharma Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-05-29 08:02:37

Marksans Pharma Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of positive signals from key technical indicators such as MACD, Bollinger Bands, and moving averages, alongside robust returns that have outpaced the broader Sensex over multiple time frames.

Read full news article

Marksans Pharma Upgraded to Buy on Strong Financial and Technical Performance

2026-05-28 08:21:29

Marksans Pharma Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across financial performance, valuation metrics, technical indicators, and overall quality. This upgrade follows the company’s robust quarterly results and positive market momentum, positioning it favourably within the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News